TIDMNSCI
NetScientific PLC
27 July 2016
("NetScientific" or the "Company" or the "Group")
Wanda Names Dr. Suzanne Steinbaum, Renowned Cardiologist and
Women's Heart Health Advocate, as Medical Director
Dr. Steinbaum joins Wanda's mission to create personalized
health guidance and accountability using advanced predictive
analytics, behavioural science, and mobile technologies.
London, UK - 27 July 2016 - NetScientific plc ("NetScientific",
AIM:NSCI), the transatlantic biomedical and healthcare technology
group, notes Wanda's announcement of the appointment of Dr. Suzanne
Steinbaum, a board-certified cardiologist and well-known national
advocate for women's heart health, as Medical Director.
Commenting on the news, François R. Martelet, Chief Executive
Officer of NetScientific, said: "Dr. Steinbaum's extensive clinical
experience and background in cardiology will make her a valuable
addition to Wanda's already distinguished team."
The full text of the announcement issued by Wanda on 26 July
2016 is as follows:
Dr. Suzanne Steinbaum, Renowned Cardiologist and Women's Heart
Health Advocate, Named Medical Director for Wanda
Dr. Steinbaum joins Wanda's mission to create personalized
health guidance and accountability using advanced predictive
analytics, behavioral science, and mobile technologies.
SAN FRANCISCO - July 26, 2016 - Wanda, a leading digital health
platform dedicated to advancing the effectiveness and efficiency of
patient care, today announced that Dr. Suzanne Steinbaum,
board-certified cardiologist and well-known national advocate for
women's heart health, has joined the company as Medical
Director.
Dr. Steinbaum is a Fellow of the American College of Cardiology
and a Fellow of the American Heart Association, and has been
trained in both Cardiology and Preventative Cardiology. She is also
a National Spokesperson for the American Heart Association's Go Red
for Women campaign and chairs Go Red for Women in New York City.
She will lend her world-class expertise and leadership to further
Wanda's mission of empowering users to improve their own health
through data-driven insights and personalized guidance.
"We're thrilled to have Dr. Steinbaum join our distinguished
team of data scientists, engineers, and designers to help us focus
on tackling mankind's number one killer: heart disease," said
Wanda's CEO Steve Curd. "Dr. Steinbaum adds an invaluable amount of
clinical competence and a deep understanding of what it takes to
keep people at risk of heart disease out of the hospital."
Wanda's digital health platform collects critical information
from individuals and utilizes machine learning to deliver ongoing
risk analysis and decision support. Combined with a smart,
inspirational, and engaging interface, Wanda's capabilities enable
users to better manage their own cardiovascular health. The result
is not only a higher quality of life, but a significant reduction
in the cost burden of these individuals.
"Wanda is at the forefront of a critical turning point in
healthcare, in which patient engagement is essential to successful
outcomes," said Dr. Steinbaum. "I have devoted my entire career to
the treatment of heart disease through early detection, education,
and prevention. The moment I met the Wanda team, I realized our
collaboration could provide an incredibly unique force in
preventing our country's number one killer. While heart disease is
80 to 90% preventable, lifestyle changes are critical, and this is
where Wanda comes in. Wanda's ability to monitor health markers and
personalize recommendations to create impactful changes for the
individual will ultimately change outcomes."
Despite the fact that over 50% of heart-related hospitalizations
are avoidable, heart disease remains one of America's most
expensive health challenges. Until now, no one has brought together
all of the pieces necessary to impact this immense problem at
scale, which drives an estimated $100 billion of cost in the US
alone.
"Instead of treating people as 'passive data sources' to be
tested, examined, treated, and often criticized for non-compliance,
we believe that the only effective approach is to engage each
individual in a meaningful dialog to personalize the experience,"
says Mark Heinemeyer, CCO for Wanda. "As we learn more about each
individual, we can guide them to make more intelligent, accountable
decisions affecting their hearts."
- Ends -
For more information, please contact:
NetScientific Tel: +44 (0)20 3514 1800
François R. Martelet,
M.D., CEO
Ian Postlethwaite, CFO
Consilium Strategic Tel: +44 (0)20 3709 5700
Communications netscientific@consilium-comms.com
Mary-Jane Elliott /
Chris Gardner / Jessica
Hodgson / Chris Welsh
/ Laura Thornton
About NetScientific Plc
NetScientific is a biomedical and healthcare technology group
that funds and develops technologies that offer transformative
benefits to people's lives and society through improved diagnosis,
prognosis and treatment. For more information, please visit the
website at www.netscientific.net.
About Wanda
San Francisco-based Wanda is dedicated to advancing the
effectiveness and efficiency of medicine by using machine learning
in place of conventional technologies and by enabling clinicians to
make more informed care decisions. Wanda recognizes that remote
monitoring and algorithms cannot save lives or reduce
hospitalizations unless the individual and their caregivers are
promptly informed and highly engaged. Through the collaboration of
data science and applied medical research, Wanda has proven that
its inline analytics predict preventable events much better than
conventional methods. Wanda serves as a diligent companion,
providing encouragement and intelligent visual guidance that
simplifies and improves lives, while simultaneously helping
organizations reduce their care delivery costs. Wanda is a
NetScientific portfolio company. More information about Wanda can
be found at www.yourwanda.com.
About Dr. Suzanne Steinbaum
Dr. Suzanne Steinbaum is an attending cardiologist and the
Director of Women's Heart Health of Lenox Hill Hospital in New York
City. She has done fellowship training in both Preventive
Cardiology and Cardiology. She recently released her book Dr.
Suzanne Steinbaum's Heart Book: Every Woman's Guide to a Heart
Healthy Life, teaching all women how to lead the healthiest lives
by living from the heart. She is the host of Focus onHealth, a
weekly magazine news show spotlighting health topics, seen on
WLNYTV. She has been awarded a New York Times Super Doctor, and a
Castle and Connolly Top Doctor for Cardiovascular Disease.
Dr. Steinbaum is a Fellow of the American College of Cardiology
and a Fellow of the American Heart Asssociation in Epidemiology and
Prevention. She is a National Spokesperson for the Go Red for Women
campaign and chairperson of Go Red for Women in New York City.
Dr. Steinbaum has devoted her career to the treatment of heart
disease through early detection, education, and prevention. She has
lectured nationally on topics of coronary artery disease, women and
heart disease, natural and alternative ways of treating heart
disease and the prevention of heart disease. She is often cited in
magazines and newspapers and is regularly seen on network news
health segments for ABC, NBC and CBS, CNN, WPIX and FOX as a
leading consultant in the field of women and heart disease,
preventive cardiology and topics of lifestyle management. She is
regularly interviewed for breaking news in U.S. News and World
Report, Healthday and WebMD. She has written on topics of cardiac
prevention and nutrition and has been quoted in many publications
and magazines, such as Self, Glamour, More, Fitness, The Wall
Street Journal and Family Circle. She is a regular contributor to
The Huffington Post, Dr. Oz, Bottomline Health, and Sharecare.
Her unique perspectives on health, wellness and overall vitality
by living a heart-centered life can be found at www.srsheart.com,
on Facebook at Dr. Suzanne Steinbaum and Twitter at
@DrSteinbaum.
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRAPGUMUMUPQGQQ
(END) Dow Jones Newswires
July 27, 2016 02:01 ET (06:01 GMT)
Netscientific (LSE:NSCI)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
Netscientific (LSE:NSCI)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024